TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: BOT-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TVPS-4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vineland Adaptive Behavior Scale-Chinese Version
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Serious Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Reaction time (in ms) of responses during go - no go cognitive task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy (in percentage) of correct responses during go - no go cognitive task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG extracted brain signals, i.e. motor-related cortical potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximally tolerated dose of bortezomib with thalidomide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Bicarbonate Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 12-months continuous smoking abstinence
Endpoint domain: Mortality/survival
Primary endpoint: Yale-Brown Obsessive-Compulsive Scale (YBOCS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ADIS C/P Interference Rating Scales
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of aspartate aminotransferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of alanine aminotransferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of creatine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Duodenal Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline values of non-HDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Level of IgG antibodies against periodontal pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Amount Eaten in Taste Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day smoking point prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with suppressed HIV (≤ 200 copies/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients without a gap in HIV primary care (without a gap > 6 months)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Complete Response (CR) by the End of Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety measured by GAD-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Burden measured by ZBI-12
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Emergency Department (ED) Visit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Life-Space Assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Independent Living Skills Survey (ILSS)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Frequency of Duchenne muscular dystrophin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in the Apnea/Hypopnea Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With a Tumor Response (PR + CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent Change in Mean Epithelial Cell Density (ECD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Postoperative Intraocular Pressure of at Least 30 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Intraoperative Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acute worsening of respiratory symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Comfort Behavior Scale (CBS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Good virologic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle sirtuin 1 (SIRT1) expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant satisfaction and perceived benefits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum lycopene and epigallocatechin-3-gallate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of fibrinogen (mg/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Measurement of hemoglobin (g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Kinetics of viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Serum cTnI concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pharmacodynamic (PD) effects on biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-perceived mouth dryness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of symptomatic cerebral hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Change in NIHSS by ≥ 4 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Child behavior during dental examination
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 14-item Perceived Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Modifications of functional MRI parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum tolerated dose or Recommended Phase 2 Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone healing condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Patient Log Ins
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of Symptom Survey Completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of biopsy-confirmed acute rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Participants Experiencing at Least One Treatment Emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Experiencing at Least One Adverse Event Leading to Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Change Over the Median BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean log transformed-area under the plasma concentration-time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of GI Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diagnosis of Antimicrobial Resistance (AMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infarct size at 30 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MACCE at 30 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CO2 Leakage Above the ETT Cuff
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically relevant postoperative pancreatic fistula (CR-POPF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: knee extensor peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ankle plantar flexors peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Overall response (CR+PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical benefit (CR+PR+SD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in Pain Intensity Between CES intervention and the control group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weighing of reflux of insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Glutamate (Glu)/Myo-inositol-containing Compounds (Ino)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glutamine (Gln)/Ino
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glutamate & Glutamine (Glx)/Ino
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of withdraw/withhold of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical complete response or pathological complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lens Comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comfort Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Markers for cardiovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Amyloid Burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Systolic and Diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of registrants on the kidney transplant waiting list
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in Methamphetamine Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication Adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Adverse Clinical Events
Endpoint domain: Adverse events/effects
Primary endpoint: Health-seeking behavior
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Monthly health expenditure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Participants With Physician Global Assessment (PGA) Score of Cleared (0) or Minimal (1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient burden from preoperative fasting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of aspiration or cancellation of surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Patients Reporting Primary Care Follow-up
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Patients Reporting New/Adjusted Hypertension Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach Cmax (tmax) of rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal half-life (t1/2) of rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of bowel colonoscopy preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Blood markers for diagnosis of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood markers for prognosis prediction of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Urine markers for diagnosis of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine markers for prognosis prediction of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity and specificity of limited CT for acute pathology detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Virologic Response 24 Weeks Post-treatment (SVR24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain as Assessed by Bieri Faces Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Before Dressing Change as assessed by r-FLACC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain After Dressing Change as assessed by r-FLACC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain as Assessed using Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS Pain Interference Survey
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: PROMIS Pain Interference Proxy Survey
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: 24 h mean value of systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of intimate partner violence
Endpoint domain: Adverse events/effects
Primary endpoint: Patient impressions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Directional error of hand trajectories towards a target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of compliance with surgical criteria
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to Successfully Intubate Patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: % of days using mehealth behavior tracking system
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lumbar spine Bone Mineral Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Failure rate in effectiveness after kidney transplant
Endpoint domain: Mortality/survival
Primary endpoint: Post-Operative Quality of Recovery Score (PQRS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Post-Operative Morbidity Survey (POMS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bladder function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Total Raw Score of Social Responsiveness Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Bone dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical symptoms assessed through daily checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With One or More Adjudicated Events of Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Time from dosing to peak concentration (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve of the analyte in plasma from zero time to infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance from incisors to anatomical landmarks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite measure of visual function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in distance walked on the six-minute walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oswestry Low Back Pain Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: incidence of HBV reactivation
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite incidence of adverse device events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Number of LH Pulses Per Hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Long-term safety assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Long-term concomitant medication assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: presence of new markers associated with transplant rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Detection rate of critical retinal findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Index of Erectile Function (IIEF) score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Sexual Encounter Profile question 2 (SEP 2) score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Sexual Encounter Profile question 3 (SEP 3) score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Presence or absence of Dose-Limiting Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Life Questionnaire (AQLQ, PAQLQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of asthma-related hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Rate of asthma-related emergency room (ER) visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidence rate of tunneled cuffed catheter-related dysfunction or bacteremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Agreement of ACT measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interchangeability of ACT measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival at 12 months follow up
Endpoint domain: Mortality/survival
Primary endpoint: Temperature amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RR interval of the heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum tolerated dose of siliphos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Success at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sputum dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Retention Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall number of treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline to Day 22 (EoT) in systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline to Day 22 (EoT) in haematology parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Baseline-Adjusted Area-Under-The-Percent-Predicted FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Identification of bacteria involved in prosthetic joint infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Collection of probabilistic antibiotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in fMRI BOLD Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plantarflexion moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak Achilles tendon load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Verbal Numeric Rating Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in sensorimotor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of aortic root growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants With Immediate Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Subjects With Solicited Local and Systemic Reactions After Vaccination 1
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Subjects With Unsolicited Adverse Events After Vaccination 1
Endpoint domain: Adverse events/effects
Primary endpoint: Average Recruitment Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Consent and Protocol Violation Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Costs of Poverty Reduction Intervention
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Healthcare Utilization Rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Efficacy of pristinamycin in MSSA bone and joint infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Survival of Tregs
Endpoint domain: Mortality/survival